JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, C. M.
Right arrow Articles by Morad, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, C. M.
Right arrow Articles by Morad, M.

Vol. 281, Issue 1, 233-244, 1997

Suppression of Mammalian K+ Channel Family by Ebastine1

Chang Mann Ko, Ivan Ducic, Jing Fan, Yaroslav M. Shuba and Martin Morad

Department of Pharmacology and Institute for Cardiovascular Sciences, Georgetown University Medical Center, Washington, D.C. 20007

Nonsedating H1 receptor (H1-R) antagonists exert variable effects on QT interval, most likely mediated through modulation of cardiac K+ channels. We examined the effects of a novel H1-R antagonist, ebastine, on a family of K+ currents in isolated rat and guinea pig ventricular cardiomyocytes as well as on HERG-induced rapidly delayed rectifier K+ current (IKr) in Xenopus laevis oocytes. The effect of ebastine was compared with that of two other H1-R antagonists, terfenadine and loratadine, with and without reported cardiotoxicity, respectively. In guinea pig ventricular myocytes, ebastine at concentrations approximating those found in plasma under certain conditions suppressed in a voltage-independent manner the IKr (Kd = 0.14 µM, maximum block 74%) more effectively than the slowly delayed rectifier K+ current (IKs) (Kd = 0.8 µM, maximum block 60%). Ebastine also suppressed IKr in HERG-expressing X. laevis oocytes with the Kd value of 0.3 µM and a maximal block of 46% at 3 µM. The block of the rapidly activating delayed rectifier channel in rat myocytes (Iped) (Kd = 1.7 µM, maximum block 58%) had a small voltage dependence. Ebastine only minimally suppressed rat transient K+ current (Ito) (Kd = 1.1 µM, maximum block 10%). The drug was also not a very potent blocker of the inwardly rectifier K+ current (IK1) of rat and guinea pig (15 ± 3% block at 3 µM). At concentrations of <100 nM, ebastine produced negligible effect on all K+ currents. We conclude that ebastine blocks various cardiac K+ channels with different potencies. The group of delayed rectifier K+ currents appeared to be most susceptible to ebastine with the order of sensitivity of IKr > IKs > Iped. Ebastine-induced inhibition of all K+ current types was always weaker than that observed with similar concentrations of terfenadine.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Physiol.Home page
J. Kurokawa, M. Tamagawa, N. Harada, S.-i. Honda, C.-X. Bai, H. Nakaya, and T. Furukawa
Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization
J. Physiol., June 15, 2008; 586(12): 2961 - 2973.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Fukuda, S. Miyoshi, K. Tanimoto, K. Oota, K. Fujikura, M. Iwata, A. Baba, Y. Hagiwara, T. Yoshikawa, H. Mitamura, et al.
Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1090 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. J. Crumb Jr.
Loratadine Blockade of K+ Channels in Human Heart: Comparison with Terfenadine under Physiological Conditions
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 261 - 264.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Taglialatela, A. Pannaccione, P. Castaldo, G. Giorgio, Z. Zhou, C. T. January, A. Genovese, G. Marone, and L. Annunziato
Molecular Basis for the Lack of HERG K+ Channel Block-Related Cardiotoxicity by the H1 Receptor Blocker Cetirizine Compared with Other Second-Generation Antihistamines
Mol. Pharmacol., July 1, 1998; 54(1): 113 - 121.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.